Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 41 | 2026 | 1014 | 4.890 |
Why?
|
| Heart Failure | 30 | 2026 | 2335 | 2.630 |
Why?
|
| Heart Transplantation | 20 | 2025 | 833 | 2.560 |
Why?
|
| Mitral Valve | 2 | 2025 | 246 | 1.510 |
Why?
|
| Warm Ischemia | 4 | 2025 | 31 | 1.440 |
Why?
|
| Prosthesis-Related Infections | 4 | 2025 | 187 | 1.130 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2026 | 228 | 1.080 |
Why?
|
| Thromboembolism | 2 | 2026 | 95 | 0.960 |
Why?
|
| Heart Neoplasms | 2 | 2025 | 108 | 0.910 |
Why?
|
| Organ Preservation | 5 | 2025 | 61 | 0.890 |
Why?
|
| Robotic Surgical Procedures | 2 | 2026 | 224 | 0.820 |
Why?
|
| Ventricular Function, Left | 4 | 2024 | 549 | 0.790 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2024 | 194 | 0.760 |
Why?
|
| Cardiac Surgical Procedures | 5 | 2025 | 1157 | 0.740 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 152 | 0.710 |
Why?
|
| Tissue Donors | 6 | 2025 | 504 | 0.700 |
Why?
|
| Middle Aged | 38 | 2026 | 28517 | 0.620 |
Why?
|
| Brain Death | 3 | 2025 | 74 | 0.620 |
Why?
|
| Aged | 29 | 2026 | 20974 | 0.610 |
Why?
|
| Retrospective Studies | 28 | 2026 | 17673 | 0.600 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2024 | 79 | 0.500 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2025 | 428 | 0.490 |
Why?
|
| Myocardium | 3 | 2025 | 863 | 0.480 |
Why?
|
| Cold Ischemia | 2 | 2025 | 28 | 0.450 |
Why?
|
| Treatment Outcome | 23 | 2025 | 12914 | 0.440 |
Why?
|
| Male | 42 | 2026 | 64772 | 0.430 |
Why?
|
| Humans | 61 | 2026 | 130870 | 0.420 |
Why?
|
| Cell Membrane | 2 | 2025 | 450 | 0.400 |
Why?
|
| Female | 38 | 2026 | 70560 | 0.390 |
Why?
|
| Time Factors | 14 | 2025 | 6217 | 0.390 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2024 | 180 | 0.390 |
Why?
|
| Thrombosis | 5 | 2022 | 498 | 0.380 |
Why?
|
| Adult | 27 | 2026 | 31245 | 0.370 |
Why?
|
| Risk Factors | 11 | 2026 | 10978 | 0.360 |
Why?
|
| Postoperative Complications | 8 | 2026 | 3131 | 0.350 |
Why?
|
| Prosthesis Implantation | 3 | 2024 | 152 | 0.310 |
Why?
|
| Hemodynamics | 6 | 2016 | 807 | 0.300 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 127 | 0.300 |
Why?
|
| Pyroptosis | 2 | 2025 | 35 | 0.280 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2023 | 106 | 0.280 |
Why?
|
| Bioprosthesis | 1 | 2008 | 111 | 0.260 |
Why?
|
| Stroke | 4 | 2024 | 1058 | 0.250 |
Why?
|
| Aspergillosis | 1 | 2007 | 47 | 0.250 |
Why?
|
| Lung Diseases, Fungal | 1 | 2007 | 38 | 0.250 |
Why?
|
| Sepsis | 2 | 2026 | 497 | 0.250 |
Why?
|
| Oxidative Phosphorylation | 2 | 2024 | 141 | 0.240 |
Why?
|
| Anticoagulants | 6 | 2022 | 605 | 0.240 |
Why?
|
| Prosthesis Design | 6 | 2016 | 617 | 0.240 |
Why?
|
| ADAM10 Protein | 1 | 2026 | 13 | 0.240 |
Why?
|
| Acute Kidney Injury | 2 | 2025 | 696 | 0.240 |
Why?
|
| Minnesota | 3 | 2016 | 180 | 0.230 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2026 | 58 | 0.230 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2026 | 72 | 0.230 |
Why?
|
| Organ Preservation Solutions | 1 | 2025 | 21 | 0.230 |
Why?
|
| Coronary Artery Bypass | 2 | 2026 | 516 | 0.230 |
Why?
|
| Endostatins | 1 | 2025 | 10 | 0.220 |
Why?
|
| Hemolysis | 2 | 2016 | 89 | 0.220 |
Why?
|
| Vascular Resistance | 2 | 2024 | 182 | 0.220 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 1082 | 0.220 |
Why?
|
| Cadherins | 1 | 2026 | 184 | 0.220 |
Why?
|
| Cystatin C | 1 | 2025 | 71 | 0.210 |
Why?
|
| Delirium | 1 | 2025 | 64 | 0.210 |
Why?
|
| Cryopreservation | 1 | 2004 | 78 | 0.210 |
Why?
|
| Heart Arrest, Induced | 1 | 2024 | 74 | 0.210 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 156 | 0.200 |
Why?
|
| Antigens, CD | 1 | 2026 | 414 | 0.200 |
Why?
|
| Shock, Cardiogenic | 3 | 2021 | 173 | 0.200 |
Why?
|
| Waiting Lists | 4 | 2020 | 245 | 0.200 |
Why?
|
| Reoperation | 3 | 2024 | 834 | 0.200 |
Why?
|
| Oxidoreductases | 1 | 2024 | 106 | 0.200 |
Why?
|
| Pneumonia | 1 | 2007 | 339 | 0.200 |
Why?
|
| NADPH Oxidases | 1 | 2024 | 108 | 0.200 |
Why?
|
| Risk Assessment | 8 | 2025 | 3694 | 0.200 |
Why?
|
| Death | 1 | 2024 | 78 | 0.190 |
Why?
|
| Biomarkers | 4 | 2026 | 3400 | 0.190 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 171 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 361 | 0.190 |
Why?
|
| Sex Factors | 3 | 2024 | 1342 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2004 | 246 | 0.190 |
Why?
|
| Edema | 1 | 2023 | 138 | 0.190 |
Why?
|
| Patient Selection | 2 | 2020 | 723 | 0.180 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 124 | 0.180 |
Why?
|
| Cancer Survivors | 1 | 2025 | 272 | 0.180 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2003 | 132 | 0.170 |
Why?
|
| Nerve Block | 1 | 2022 | 69 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1493 | 0.170 |
Why?
|
| Heart Ventricles | 3 | 2013 | 762 | 0.170 |
Why?
|
| Hyponatremia | 1 | 2022 | 72 | 0.170 |
Why?
|
| Kidney | 2 | 2025 | 1283 | 0.170 |
Why?
|
| Phage Therapy | 1 | 2021 | 52 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 438 | 0.170 |
Why?
|
| Machine Learning | 1 | 2024 | 386 | 0.160 |
Why?
|
| Survival Rate | 3 | 2016 | 2140 | 0.160 |
Why?
|
| Recovery of Function | 2 | 2016 | 446 | 0.160 |
Why?
|
| Nephrology | 1 | 2022 | 159 | 0.160 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 5199 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 164 | 0.150 |
Why?
|
| HIV-1 | 1 | 2022 | 484 | 0.150 |
Why?
|
| Inflammation | 2 | 2023 | 1478 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 775 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 662 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2026 | 892 | 0.140 |
Why?
|
| Transplant Recipients | 1 | 2020 | 228 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 256 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2026 | 675 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2026 | 1605 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 482 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 901 | 0.140 |
Why?
|
| Assisted Circulation | 2 | 2016 | 23 | 0.140 |
Why?
|
| Organ Transplantation | 1 | 2020 | 170 | 0.140 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 294 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 255 | 0.130 |
Why?
|
| Hospital Mortality | 3 | 2023 | 1066 | 0.130 |
Why?
|
| Hematologic Agents | 1 | 2015 | 8 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 1405 | 0.120 |
Why?
|
| Histocompatibility | 1 | 2015 | 42 | 0.120 |
Why?
|
| Transfusion Reaction | 1 | 2015 | 42 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2019 | 431 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 504 | 0.110 |
Why?
|
| Adolescent | 6 | 2025 | 20820 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3428 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2025 | 6450 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 904 | 0.100 |
Why?
|
| ROC Curve | 2 | 2026 | 607 | 0.100 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 111 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2017 | 381 | 0.100 |
Why?
|
| Catheter Ablation | 2 | 2013 | 321 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 235 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1158 | 0.100 |
Why?
|
| Brain | 1 | 2025 | 3201 | 0.090 |
Why?
|
| Atrial Flutter | 1 | 2013 | 45 | 0.090 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 73 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 156 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 248 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 563 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2022 | 1501 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2013 | 359 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 2957 | 0.080 |
Why?
|
| HIV Infections | 1 | 2022 | 2036 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2013 | 256 | 0.080 |
Why?
|
| Young Adult | 3 | 2013 | 10042 | 0.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2022 | 40 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 677 | 0.070 |
Why?
|
| Heart Arrest | 1 | 2013 | 377 | 0.070 |
Why?
|
| Prognosis | 3 | 2025 | 4913 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 178 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2017 | 5095 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 1001 | 0.060 |
Why?
|
| Pancreas Transplantation | 1 | 2007 | 30 | 0.060 |
Why?
|
| Calcinosis | 1 | 2008 | 181 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2024 | 1228 | 0.060 |
Why?
|
| Incidence | 3 | 2025 | 3336 | 0.060 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2025 | 16 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2007 | 144 | 0.060 |
Why?
|
| Procaine | 1 | 2025 | 12 | 0.060 |
Why?
|
| Caspase 1 | 1 | 2025 | 49 | 0.060 |
Why?
|
| Disaccharides | 1 | 2025 | 19 | 0.060 |
Why?
|
| Ikaros Transcription Factor | 1 | 2025 | 35 | 0.060 |
Why?
|
| Mannitol | 1 | 2025 | 40 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2025 | 40 | 0.060 |
Why?
|
| Glutamates | 1 | 2025 | 54 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2010 | 451 | 0.060 |
Why?
|
| Histidine | 1 | 2025 | 69 | 0.060 |
Why?
|
| Electrolytes | 1 | 2025 | 59 | 0.060 |
Why?
|
| Coenzyme A Ligases | 1 | 2025 | 13 | 0.060 |
Why?
|
| Preoperative Period | 1 | 2025 | 90 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 92 | 0.050 |
Why?
|
| Edema, Cardiac | 1 | 2004 | 4 | 0.050 |
Why?
|
| Registries | 2 | 2022 | 1617 | 0.050 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 126 | 0.050 |
Why?
|
| Atrophy | 1 | 2025 | 246 | 0.050 |
Why?
|
| Equipment Design | 2 | 2021 | 542 | 0.050 |
Why?
|
| Glutathione | 1 | 2025 | 202 | 0.050 |
Why?
|
| Organ Size | 1 | 2025 | 421 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 243 | 0.050 |
Why?
|
| Intraoperative Period | 1 | 2003 | 66 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 3040 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2112 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 149 | 0.050 |
Why?
|
| Iron | 1 | 2025 | 305 | 0.040 |
Why?
|
| Graft Survival | 1 | 2024 | 462 | 0.040 |
Why?
|
| Age Factors | 3 | 2014 | 2842 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 420 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2025 | 389 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 521 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2007 | 563 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2017 | 940 | 0.040 |
Why?
|
| Glucose | 1 | 2025 | 855 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2023 | 211 | 0.040 |
Why?
|
| Alleles | 1 | 2025 | 1689 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2022 | 213 | 0.040 |
Why?
|
| Autophagy | 1 | 2022 | 424 | 0.040 |
Why?
|
| Algorithms | 1 | 2025 | 1682 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3393 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2025 | 1842 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 482 | 0.030 |
Why?
|
| Apoptosis | 1 | 2004 | 1844 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 484 | 0.030 |
Why?
|
| Hyperbilirubinemia | 1 | 2017 | 43 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 1977 | 0.030 |
Why?
|
| Postoperative Care | 2 | 2010 | 297 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2849 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2010 | 359 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2025 | 2454 | 0.030 |
Why?
|
| Child | 2 | 2025 | 26218 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2014 | 45 | 0.030 |
Why?
|
| Acute Disease | 2 | 2008 | 1152 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2014 | 111 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1380 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2010 | 1343 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 276 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 345 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 294 | 0.020 |
Why?
|
| Electric Countershock | 1 | 2013 | 75 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 1805 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1612 | 0.020 |
Why?
|
| Biopsy | 1 | 2014 | 1244 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 2082 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 346 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 860 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13299 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 15018 | 0.020 |
Why?
|
| Pulse | 1 | 2009 | 28 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1892 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2907 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2303 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2008 | 50 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 318 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 136 | 0.020 |
Why?
|
| Safety | 1 | 2009 | 215 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 307 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 1681 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 157 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 419 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 976 | 0.020 |
Why?
|
| Warfarin | 1 | 2008 | 123 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1935 | 0.020 |
Why?
|
| Aspirin | 1 | 2008 | 215 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 2010 | 623 | 0.010 |
Why?
|
| Creatinine | 1 | 2007 | 398 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2008 | 493 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2007 | 541 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4683 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3827 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6801 | 0.010 |
Why?
|
| Decision Making | 1 | 2007 | 692 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2007 | 949 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 18268 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 33982 | 0.010 |
Why?
|